The mean MICRA-J Total scores of the BRCA1/2-positive groups in this study (32.2 for Group 1 and 25.7 for Group 4) were within the approximate range of 27.5 for affected and unaffected women with BRCA1/2 pathogenic variants in the original MICRA report [4] and 38.6 in a previous study of patients with ovarian cancer and BRCA1/2 pathogenic variants [7]. This evidence concerns the gene BRCA1 and ovarian cancer.